The purpose of this article is to review prominent studies on HIV drug-resistance in mothers
and their infants after the use of antiretroviral drugs to prevent mother-to-child-transmission …

Transmission of HIV viruses harboring resistance mutations is already a major concern in
developed countries, with the potential to impact on therapeutic strategies. Several factors …

Administration of potent antiretroviral combination therapy in the second and third trimester
of pregnancy and during delivery, and for 6 weeks postpartum to the infant, may reduce HIV …

Objective: To characterize concordance of resistance mutations to antiretroviral drugs (ART)
in mother–infant pairs. Design: Case series of HIV-transmitting mothers and infants in the …

Here, we summarize the discussions and conclusions from an expert workshop held in
October 2012 to consider the implications of HIV drug resistance in the context of scale-up of …

Background We aimed to assess if maternal human immunodeficiency virus (HIV) drug
resistance is associated with an increased risk of HIV vertical transmission and to describe …

Abstract Purpose of Review With the expanded roll-out of antiretrovirals for treatment and
prevention of HIV during the last decade, the emergence of HIV drug resistance (HIVDR) …

Abstract Pediatric AIDS Clinical Trials Group protocol 316 was an international, multicenter,
placebo-controlled trial comparing single-dose oral nevirapine (200 mg to mother and 2 …

In high-income and some middle-income countries, effective programs to prevent mother-to-
child transmission (PMTCT) using combination antiretroviral therapy (ART) for pregnant HIV …

To assess the impact of antiretroviral resistance on perinatal transmission prevention efforts,
human immunodeficiency virus type 1 (HIV-1) genotypic resistance testing was done for 220 …